Skip to search formSkip to main contentSkip to account menu

imazodan

Known as: 4,5-dihydro-6-(4-(1H-imidazol-1-yl)phenyl)-3(2H)-pyridazinone 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

CI 914imazodan hydrochloride

Broader (3)

Cardiotonic AgentsPhosphodiesterase InhibitorsPyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Effectiveness of lmazodan for Treatment of Chronic Congestive Heart Failure
A 12=week, multicenter, double-blind, randomized, placebo-controlled trial of imazodan, a type Ill phosphodiisterase inhibitor… 
1993
1993
Synthesis and cardiotonic activity of 2-alkyl-thio-1-acyl-5,6-methylene(or ethylene)dioxy-benzimidazoles and their cyclic analogs
The widespread incidence of congested cardiac insufficiency and the low therapeutic effect of cardiac glycosides, used for their… 
1990
1990
Inotropic and Chronotropic Profile of MCI-154: Comparison with Isoproterenol and Imazodan in Guinea Pig Cardiac Preparations
Summary: Although recent studies indicate that MCI-154 exerts novel positive inotropic actions in heart muscle, the chronotropic… 
1989
1989
SYNTHESIS OF IMAZODAN
Imazodan, a novel cardiotonic, was prepared. The yield of acyla-tion was increased by improved reaction conditions, and sodium… 
1989
1989
[Effects of imazodan and dazoxiben on cAMP levels and PGI2 production in cultured bovine aortic endothelial cells].
We have investigated the effects of imazodan, a potent inhibitor of phosphodiesterase III (PDE III) and dazoxiben, a selective… 
1986
1986
The Effect of the Cardiotonic Imazodan (CI‐914) on Myocardial and Peripheral Hemodynamics in the Anesthetized Dog
Summary: The purpose of this study was to evaluate the effect of the new cardiotonic, imazodan (CI-914), on myocardial…